News

February 19, 2018

Medicine-for-All Institute (VCU) selects BPP as First Commercial Manufacturing Partner

RICHMOND, VA  — Bright Path Pharmaceuticals, LLC (privately held) today announced that the Medicines for All Institute, a joint venture between Virginia Commonwealth University and the […]
December 8, 2017

ChemWerth’s Dr. Xiping Su joins BPP’s Board

RICHMOND, VA  —  Bright Path Pharmaceuticals, LLC (privately held), today announced that ChemWerth’s Chief Scientific Officer, Dr. Xiping Su, has joined the Board of the company following […]
August 28, 2017

Todd N. Smith joins BPP Board

CHARLOTTE, NC — Bright Path Pharmaceuticals, LLC (privately held) today announced that Todd N. Smith, Chairman and CEO of Novum Pharma will join the Board.  Mr. […]
July 1, 2017

Luther H. Hodges Jr. joins BPP’s Board

CHARLOTTE, NC — Bright Path Pharmaceuticals, LLC (privately held), today announced that Luther H. Hodges Jr. will join the Board of Directors.  Mr. Hodges is an active […]
June 30, 2017

Dr. Christopher W. McDaniel joins BPP as CSO

CHARLOTTE, NC — Bright Path Pharmaceuticals, LLC (privately held) today announced that Dr. Christopher W. McDaniel joins the company as Chief Scientific Officer and will lead BPP’s […]
May 8, 2017

Pharma Industry Executive, Jon A. Kleu joins BPP’s Board

CHARLOTTE, NC — Bright Path Pharmaceuticals, LLC (privately held) today announced that Jon A. Kleu, Vice President of Sales for Syneos Health (Nasdaq:SYNH), a fully integrated biopharmaceutical […]
May 2, 2017

BPP Corporate Formation

CHARLOTTE, NC — Bright Path Pharmaceuticals, LLC (privately held), a developmental stage bio-pharmaceutical manufacturing company, is developing first-in-class continuous-flow technologies  solely focused on the production of active […]